Healthcare provider profile · identity verified

Cassidy H Prentice, PAC

Physician Assistant · ZEBULON, NC · NPI 1689009169

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	336	98
Levothyroxine Sodium	Levothyroxine Sodium	334	93
Amlodipine Besylate	Amlodipine Besylate	299	79
Lisinopril	Lisinopril	235	63
Omeprazole	Omeprazole	229	75
Gabapentin	Gabapentin	212	64
Losartan Potassium	Losartan Potassium	176	50
Trazodone Hcl	Trazodone Hcl	159	51
Hydrochlorothiazide	Hydrochlorothiazide	118	37
Metformin Hcl	Metformin Hcl	117	32
Rosuvastatin Calcium	Rosuvastatin Calcium	107	39
Bupropion Xl	Bupropion Hcl	102	31
Prednisone	Prednisone	99	71
Pantoprazole Sodium	Pantoprazole Sodium	98	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	93	33
Lorazepam	Lorazepam	93	18
Metoprolol Succinate	Metoprolol Succinate	92	30
Simvastatin	Simvastatin	91	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	85	70
Escitalopram Oxalate	Escitalopram Oxalate	85	22
Tamsulosin Hcl	Tamsulosin Hcl	83	29
Albuterol Sulfate Hfa	Albuterol Sulfate	81	43
Meloxicam	Meloxicam	76	22
Duloxetine Hcl	Duloxetine Hcl	75	23
Zolpidem Tartrate	Zolpidem Tartrate	70	22
Tramadol Hcl	Tramadol Hcl	69	21
Alprazolam	Alprazolam	68	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	33
Carvedilol	Carvedilol	66	23
Spironolactone	Spironolactone	64	19
Alendronate Sodium	Alendronate Sodium	63	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	15
Sertraline Hcl	Sertraline Hcl	63	17
Furosemide	Furosemide	58	23
Jardiance	Empagliflozin	51	16
Mounjaro	Tirzepatide	51	suppressed
Allopurinol	Allopurinol	50	16
Metoprolol Tartrate	Metoprolol Tartrate	49	14
Fluconazole	Fluconazole	48	26
Triamcinolone Acetonide	Triamcinolone Acetonide	48	33
Cephalexin	Cephalexin	47	37
Eliquis	Apixaban	47	15
Citalopram Hbr	Citalopram Hydrobromide	46	11
Montelukast Sodium	Montelukast Sodium	44	16
Oxybutynin Chloride Er	Oxybutynin Chloride	44	15
Ozempic	Semaglutide	43	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	11
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Synthroid	Levothyroxine Sodium	40	12
Dicyclomine Hcl	Dicyclomine Hcl	39	suppressed
Famotidine	Famotidine	36	12
Finasteride	Finasteride	36	14
Lovastatin	Lovastatin	35	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	33
Ezetimibe	Ezetimibe	34	suppressed
Celecoxib	Celecoxib	31	11
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	11
Doxycycline Hyclate	Doxycycline Hyclate	29	21
Tizanidine Hcl	Tizanidine Hcl	29	11
Warfarin Sodium	Warfarin Sodium	29	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	28	11
Estradiol	Estradiol	27	13
Potassium Chloride	Potassium Chloride	26	12
Lamotrigine	Lamotrigine	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	12
Buspirone Hcl	Buspirone Hcl	22	12
Enalapril Maleate	Enalapril Maleate	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Ondansetron Odt	Ondansetron	22	11
Oxycodone Hcl	Oxycodone Hcl	22	18
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Atenolol	Atenolol	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Clozapine	Clozapine	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Ciclopirox	Ciclopirox	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Diazepam	Diazepam	16	12
Farxiga	Dapagliflozin Propanediol	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Buprenorphine	Buprenorphine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Nystatin	Nystatin	15	12
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Testosterone	Testosterone	15	suppressed
Valsartan	Valsartan	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Glipizide Er	Glipizide	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Azithromycin	Azithromycin	12	12
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error